LILLY 4165

Generic Name: raloxifene

Pill imprint LILLY 4165 has been identified as Evista 60 mg.

Evista is used in the treatment of osteoporosis; prevention of osteoporosis; breast cancer, prevention and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy.

Evista 60 mg is not subject to the Controlled Substances Act.
See also related documents.

Evista Images

Generic Name:
raloxifene
Imprint:
LILLY 4165
Strength:
60 mg
Color:
White
Size:
12.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Inactive Ingredients:
carnauba wax
crospovidone
hypromelloses
lactose monohydrate
lactose anhydrous
magnesium stearate
polyethylene glycol
povidone
titanium dioxide
polysorbate 80
propylene glycol
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lilly, Eli and Company
National Drug Code (NDC):
00002-4165
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4628 A S Medication Solutions LLC (repackager)
54868-4170 Physicians Total Care Inc (repackager)
57866-0002 Direct Dispensing Inc (repackager)
55289-0266 PDRX Pharmaceuticals Inc (repackager)
49999-0458 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Evista 60 mg LILLY 4165  Front
Evista 60 mg LILLY 4165  Back
Evista 60 mg LILLY 4165
Evista 60 mg LILLY 4165
Advertisement

Evista is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)